CJC-1295 is a synthetic GHRH analog that stimulates GH release, commonly stacked with ipamorelin, and is used by the community for sleep quality and recovery, muscle growth and fat loss, and anti-aging. Typical protocols involve doses of 200 mcg/day, although reported doses range from 100 mcg to 25 mg/day. Sleep and dream effects are commonly reported, while injection-site reactions and other side effects have not been a consistent theme in community reports.
Data last updated
Measured on 5 of 6 axes
Evidence shape
Human evidence for CJC-1295 is limited — pilot studies, withdrawn trials, or completed trials without posted results. Off-label / exploratory data exists for 2 additional indications (Treatment studies; Diagnostic & mechanistic studies). 1 trial was withdrawn or terminated — surfaced below as signal of absence, not omitted.
Efficacy signal
Completed studies are present, but primary-endpoint pass/fail classification is not yet clean enough to score. These are the currently projected indication-level signals.
HIV-associated lipodystrophy — visceral fat reduction
1 study
Treatment studies
2 studies
Diagnostic & mechanistic studies
2 studies
No completed study rows are available for endpoint scoring yet.
Human evidence
Lower-tier support
Published literature
Standalone PubMed / Europe PMC publications matched to this peptide and deduped by identifier. Trial records and animal / in-vitro rows are surfaced above; these are the human-relevant papers behind them.
Source data
Clinical research side effects
Grouped from 2 published human studies — weighted by study count, not incidence (the papers report no rates).
Anecdotal side effects
price offers can be sorted by column
How CJC-1295 is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.
No structured protocol details captured for this tier yet.
In research trials, CJC-1295 was given at 30–60 µg per kilogram of body weight each week; no fixed milligram dose was specified.
No structured protocol details captured for this tier yet.
Community users most often cite 200 mcg as a reference amount, with reported doses spanning 100 mcg to 25 mg; among the few who specify a schedule, some take it twice daily and others daily, while many do not state a frequency.